|
FY2021
12 months to Dec 31, 2021
|
FY2020
3 months to Dec 31, 2020
|
|
|---|---|---|
| Cash flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Other expense relating to fair value exceeding amount paid for warrants | ||
| Unrealized gain on change in fair value of warrants | ||
| Unrealized loss on change in fair value of over-allotment option | ||
| Interest earned on marketable securities held in Trust Account | ||
| Changes in current assets and current liabilities: | ||
| Prepaid expenses | ||
| Accrued offering costs and expenses | ||
| Due to related party | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment held in Trust Account | ||
| Net cash used in investing activities | ||
| Cash flows from Financing Activities: | ||
| Proceeds from issuance of founder’s share | ||
| Proceeds from initial public offering, net of underwriters’ fee | ||
| Proceeds from over-allotment, net of underwriters’ fees | ||
| Proceeds from private placement | ||
| Proceeds from issuance of promissory note to related party | ||
| Payment of deferred offering costs | ||
| Payment to promissory note to related party | ||
| Payment of deferred offering costs | ||
| Net cash provided by financing activities | ||
| Cash, September 23, 2020 (inception) | ||
| Net change in cash | ||
| Cash, beginning of the period | ||
| Cash, end of the period | ||
| Supplemental disclosure of non-cash activities | ||
| Deferred underwriting commissions charged to additional paid in capital | ||
| Remeasurement of Class A common stock to redemption value | ||
| Accrued deferred offering costs | ||
| Issuance of representative shares |
Loading...
